Skip to main content

View full-text article in PMC

. 2018 Jul 7;68(6):927–933. doi: 10.1093/cid/ciy574

Table 3.

Impetigo Culture Results

		Baseline	3 Months	12 Months
		Organism Isolated (%, 95% CI)	Organism Isolated (%, 95% CI)	Organism Isolated (%, 95% CI)
Ivermectin only	Staphylococcus aureus	27/35 (77%, 59–89%)	13/19 (68%, 43–86%)	6/6 (100%, 52–100%)
	Pyogenic streptococci^a	28/35^b (80%, 63–91%)	9/19^c (47%, 25–71%)	1/6 (17%, 9–64%)
Combined treatment	Staphylococcus aureus	32/38 (84%, 68–93%)	15/17 (88%, 62–98%)	13/16 (81%,54–95%)
	Pyogenic streptococci^a	17/38^b (45%, 29–63%)	5/17^c (29%, 11–56%)	4/16 (25%, 8–53%)
Total	Staphylococcus aureus	59/73 (81%, 70–89%)	28/36 (78%, 60–89%)	19/22 (86%, 64–96%)
	Pyogenic streptococci^a	45/73 (62%, 49–73%)	14/36 (39%, 24–56%)	5/22 (23%, 9–46%)

Abbreviation: CI, confidence interval.

^aFor simplicity we report Group C/G streptococci alongside Streptococcus pyogenes.

^bOne group C/G streptococcus in the ivermectin-only treatment arm and 4 in the combined treatment arm.

^cTwo group C/G streptococcus in the ivermectin-only treatment arm.